Should Johnson & Johnson Split Up?

Our health care roundtable gathers the Motley Fool's top health care analysts to discuss the sector's biggest stories in a free flowing and highly opinionated format. 

In this portion of the discussion, the Fool's health care team tackles the recent big pharma trend of spinning off whole divisions, like Abbott Labs' (NYSE: ABT  ) plans for pharmaceutical-focused AbbVie. Would  conglomerate Johnson & Johnson (NYSE: JNJ  ) benefit from shedding a little extra weight and spinning off a company or two?

None


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2420218, ~/Articles/ArticleHandler.aspx, 9/23/2014 6:49:07 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement